Stokes Bio Ltd.
Tuesday, 04 May 2010
Advised the shareholders of Stokes Bio on the sale of their shareholdings in Stokes Bio Limited as part of a trade sale of the firm to NASDAQ quoted Life Technologies (total sale consideration US$44m).
Advised the shareholders of Stokes Bio on the sale of their shareholdings in Stokes Bio Limited as part of a trade sale of the firm to NASDAQ quoted Life Technologies (total sale consideration US$44m).